Sahin Cigdem, Tseng Yu-Hua
Section on Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA.
Physiology (Bethesda). 2025 Aug 1. doi: 10.1152/physiol.00006.2025.
Thermogenic adipose tissues, including brown and beige, exhibit remarkable cellular and metabolic adaptations to environmental and physiological cues, contributing to improved metabolic health. Among these adaptations, adipose progenitor cells (APCs), a heterogeneous cell population comprising distinct subsets, play a crucial role in generating thermogenic adipocytes and promoting healthy adipose tissue remodeling and metabolic homeostasis. Therefore, targeting APCs offers a potential therapeutic approach for regulating adipose plasticity and remodeling to address metabolic dysregulation. The precise identity of APCs and the roles of specific APC subtypes in metabolic regulation and diseases remain to be elucidated. Here, we summarize recent findings on the lineage of APCs that give rise to thermogenic adipocytes and how environmental conditions regulate their proliferation and differentiation. Finally, we discuss the potential of targeting APCs as an alternative therapeutic strategy to combat metabolic diseases.
产热脂肪组织,包括棕色和米色脂肪组织,对环境和生理信号表现出显著的细胞和代谢适应性,有助于改善代谢健康。在这些适应性变化中,脂肪祖细胞(APC)是一个由不同亚群组成的异质性细胞群体,在生成产热脂肪细胞以及促进健康的脂肪组织重塑和代谢稳态方面发挥着关键作用。因此,靶向脂肪祖细胞为调节脂肪可塑性和重塑以解决代谢失调提供了一种潜在的治疗方法。脂肪祖细胞的确切身份以及特定脂肪祖细胞亚群在代谢调节和疾病中的作用仍有待阐明。在此,我们总结了关于产生产热脂肪细胞的脂肪祖细胞谱系的最新研究结果,以及环境条件如何调节它们的增殖和分化。最后,我们讨论了将靶向脂肪祖细胞作为对抗代谢疾病的替代治疗策略的潜力。